AR049588A1 - Saliciltiazoles sustituidos con difenilamina o derivados de difenilamina como inhibidores de receptores ptp1b - Google Patents
Saliciltiazoles sustituidos con difenilamina o derivados de difenilamina como inhibidores de receptores ptp1bInfo
- Publication number
- AR049588A1 AR049588A1 ARP050102922A ARP050102922A AR049588A1 AR 049588 A1 AR049588 A1 AR 049588A1 AR P050102922 A ARP050102922 A AR P050102922A AR P050102922 A ARP050102922 A AR P050102922A AR 049588 A1 AR049588 A1 AR 049588A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- difenylamine
- aryl
- saliciltiazoles
- ptp1b
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
Abstract
Composiciones farmacéuticas que los contienen y usos para el tratamiento y prevencion de la diabetes. Reivindicacion 1: Un compuesto de formula (1), en la que los significados son R1, R2, R3, R4, R5 de modo independiente entre sí, H, F, Cl, Br, I, OH, CF3, NO2, CN, OCF3, O-(alquilo C1-6), O-alcoxi (C1-4)-alquilo (C1-4), S-alquilo (C1-6), alquilo (C1-6), alquenilo (C2-6), cicloalquilo (C3-8), O-cicloalquilo (C3-8), cicloalquenilo (C3-8), O-cicloalquenilo (C3-8), alquinilo (C2-6), arilo, O-aril- alquilen (C1-8)-arilo, O-alquilen (C1-8)-arilo, S-arilo, CO-NH-alquilo (C1-6), N(alquilo (C1-6))2, NH-SO2-CH3, SO2-CH3, COOH, COO-alquilo (C1-6), CO-N(alquilo (C1-6))2; R6 es H, alquilo (C1-6); A es un enlace, -CH2-, -NH-, -CH2-O-, -S-, -CH2-CH2, - CH(CH3)-; B es NH, NH-alquilo (C1-4), NH(CO); D es fenilo, heterociclo; y sus sales fisiologicamente toleradas
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004034697A DE102004034697A1 (de) | 2004-07-17 | 2004-07-17 | Mit Diphenylamin oder Diphenylaminderivaten substituierte Salicylthiazole, Verfahren zu deren Herstellung und deren Verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR049588A1 true AR049588A1 (es) | 2006-08-16 |
Family
ID=34971604
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050102922A AR049588A1 (es) | 2004-07-17 | 2005-07-14 | Saliciltiazoles sustituidos con difenilamina o derivados de difenilamina como inhibidores de receptores ptp1b |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7741491B2 (es) |
| EP (1) | EP1771426B1 (es) |
| JP (1) | JP2008506643A (es) |
| KR (1) | KR20070043787A (es) |
| CN (1) | CN100582098C (es) |
| AR (1) | AR049588A1 (es) |
| AT (1) | ATE381551T1 (es) |
| AU (1) | AU2005263418A1 (es) |
| BR (1) | BRPI0513423A (es) |
| CA (1) | CA2574162A1 (es) |
| DE (2) | DE102004034697A1 (es) |
| DK (1) | DK1771426T3 (es) |
| ES (1) | ES2296199T3 (es) |
| HK (1) | HK1104534A1 (es) |
| IL (1) | IL180570A0 (es) |
| MX (1) | MXPA06014443A (es) |
| PE (1) | PE20060554A1 (es) |
| PT (1) | PT1771426E (es) |
| TW (1) | TW200616985A (es) |
| UY (1) | UY29020A1 (es) |
| WO (1) | WO2006007959A1 (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| UY31968A (es) | 2008-07-09 | 2010-01-29 | Sanofi Aventis | Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos |
| WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
| CA2771278A1 (en) | 2009-08-26 | 2011-03-03 | Sanofi | Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use |
| WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
| US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| EP2683699B1 (de) | 2011-03-08 | 2015-06-24 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120053A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001074793A2 (en) * | 2000-04-03 | 2001-10-11 | 3-Dimensional Pharmaceuticals, Inc. | Substituted thiazoles and the use thereof as inhibitors of plasminogen activator inhibitor-1 |
| EP1446110A2 (en) * | 2001-10-16 | 2004-08-18 | Structural Bioinformatics Inc. | Organosulfur inhibitors of tyrosine phosphatases |
| CA2469228A1 (en) * | 2001-12-03 | 2003-06-12 | Japan Tobacco Inc. | Azole compound and medicinal use thereof |
| CN101103977A (zh) * | 2002-06-05 | 2008-01-16 | 株式会社医药分子设计研究所 | 糖尿病治疗药 |
-
2004
- 2004-07-17 DE DE102004034697A patent/DE102004034697A1/de not_active Withdrawn
-
2005
- 2005-07-02 PT PT05756578T patent/PT1771426E/pt unknown
- 2005-07-02 KR KR1020077001132A patent/KR20070043787A/ko not_active Application Discontinuation
- 2005-07-02 BR BRPI0513423-4A patent/BRPI0513423A/pt not_active IP Right Cessation
- 2005-07-02 DE DE502005002310T patent/DE502005002310D1/de active Active
- 2005-07-02 EP EP05756578A patent/EP1771426B1/de not_active Not-in-force
- 2005-07-02 CA CA002574162A patent/CA2574162A1/en not_active Abandoned
- 2005-07-02 CN CN200580024146A patent/CN100582098C/zh not_active Expired - Fee Related
- 2005-07-02 DK DK05756578T patent/DK1771426T3/da active
- 2005-07-02 AU AU2005263418A patent/AU2005263418A1/en not_active Abandoned
- 2005-07-02 MX MXPA06014443A patent/MXPA06014443A/es active IP Right Grant
- 2005-07-02 AT AT05756578T patent/ATE381551T1/de not_active IP Right Cessation
- 2005-07-02 WO PCT/EP2005/007151 patent/WO2006007959A1/de active IP Right Grant
- 2005-07-02 ES ES05756578T patent/ES2296199T3/es active Active
- 2005-07-02 JP JP2007520705A patent/JP2008506643A/ja not_active Abandoned
- 2005-07-11 PE PE2005000803A patent/PE20060554A1/es not_active Application Discontinuation
- 2005-07-14 TW TW094123824A patent/TW200616985A/zh unknown
- 2005-07-14 AR ARP050102922A patent/AR049588A1/es not_active Application Discontinuation
- 2005-07-15 UY UY29020A patent/UY29020A1/es unknown
-
2006
- 2006-12-12 US US11/609,463 patent/US7741491B2/en not_active Expired - Fee Related
-
2007
- 2007-01-04 IL IL180570A patent/IL180570A0/en unknown
- 2007-09-05 HK HK07109657.8A patent/HK1104534A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US20070191441A1 (en) | 2007-08-16 |
| KR20070043787A (ko) | 2007-04-25 |
| PE20060554A1 (es) | 2006-06-24 |
| TW200616985A (en) | 2006-06-01 |
| US7741491B2 (en) | 2010-06-22 |
| ATE381551T1 (de) | 2008-01-15 |
| PT1771426E (pt) | 2008-01-31 |
| CN1989116A (zh) | 2007-06-27 |
| EP1771426A1 (de) | 2007-04-11 |
| EP1771426B1 (de) | 2007-12-19 |
| CN100582098C (zh) | 2010-01-20 |
| AU2005263418A1 (en) | 2006-01-26 |
| DE502005002310D1 (de) | 2008-01-31 |
| UY29020A1 (es) | 2006-02-24 |
| IL180570A0 (en) | 2007-06-03 |
| DE102004034697A1 (de) | 2006-02-09 |
| BRPI0513423A (pt) | 2008-05-06 |
| JP2008506643A (ja) | 2008-03-06 |
| MXPA06014443A (es) | 2007-03-21 |
| DK1771426T3 (da) | 2008-05-05 |
| HK1104534A1 (en) | 2008-01-18 |
| WO2006007959A1 (de) | 2006-01-26 |
| CA2574162A1 (en) | 2006-01-26 |
| ES2296199T3 (es) | 2008-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR049588A1 (es) | Saliciltiazoles sustituidos con difenilamina o derivados de difenilamina como inhibidores de receptores ptp1b | |
| AR058546A1 (es) | Derivados de 2- adamantilurea como inhibidores selectivos de 11 beta - hsd1 | |
| HRP20050543A2 (en) | Substituted indolepyridinium as anti-infective compounds | |
| AR053554A1 (es) | Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos | |
| AR060991A1 (es) | Acidos carboxilicos sustituidos con 4,5-difenilpirimidinilo y composiciones farmaceuticas que los contienen utilizadas para el tratamiento de la diabetes | |
| CY1117085T1 (el) | C7-φθορο υποκατεστημενες ενωσεις τετρακυκλινης | |
| AR081834A1 (es) | N-[(het)arilalquil)]pirazolocarboxamidas o tiocarboxamidas y analogos heterosustituidos, composiciones funguicidas que los contienen y metodos para el control de hongos fitopatogenos en cultivos usando dichos compuestos o sus composiciones | |
| AR042658A1 (es) | Derivados de 1,5-diaril-pirrol-3-carboxamida y su uso como moduladores de receptores canabinoides | |
| AR079541A1 (es) | Compuestos sustituidos de n-(1h-indazol-4-il) imidazo (1,2-a) piridin-3-carboxamida como inhibidores de cfms | |
| PE20090042A1 (es) | Analogos de ciclopamina | |
| AR075717A1 (es) | Compuestos de 3- aril quinazolin -4- ona para combatir plagas de invertebrados | |
| AR063988A1 (es) | Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| PE20090159A1 (es) | COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs | |
| CO6280485A2 (es) | Inhibidores de 11-beta hidroxiesteroide deshidrogenasa tipo i de triazolopiridina | |
| AR074604A1 (es) | Derivados de 5-amino-2-(1-hidroxi-etil)-tetrahidropirano. | |
| AR051921A1 (es) | Acidos sustituidos utiles como compuestos farmaceuticos para tratar trastornos respiratorios, composiciones farmaceuticas que los contienen, y procesos para su preparacion | |
| AR076435A1 (es) | Compuestos de indazoles sustituidos, composiciones farmaceuticas que los contienen y procesos de obtencion de los mismos | |
| AR037754A1 (es) | Herbicidas | |
| ECSP045004A (es) | Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades andrógeno dependientes | |
| AR067646A1 (es) | Ariloxazoles sustituidos y su uso | |
| UY30391A1 (es) | Compuesto de oximilo aciclico inhibidores de proteasa de hepatitis c | |
| AR083017A1 (es) | Prodrogas de ester de [3-(1-(1h-imidazol-4-il)etil)-2-metilfenil]metanol | |
| EA200900631A1 (ru) | Замещённые пиразолы и триазолы, как ингибиторы кбв (кинезин-белок веретена) | |
| UY30787A1 (es) | "inhibidores benzoimidazolicos de trpv1" | |
| AR067927A1 (es) | Quinolinas sustituidas, composiciones y combinaciones que las comprenden y el uso de las mismas en la preparacion de un medicamento para tratamiento de enfermedades inflamatorias y/o alergicas del tracto respiratorio. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |